ArticleNucleic acids research2026
xBind: an integrated webserver for large language model-enabled cross-molecular protein binding site prediction.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
xBind is an interactive, freely accessible, and fully configurable webserver for large language model (LLM)-enabled cross-molecular protein binding-site prediction. xBind leverages LLM embeddings from the ESM-2 model together with sequence- and structure-derived features to predict protein-protein, protein-DNA, and protein-RNA binding sites using symmetry-aware deep graph neural networks. The input to xBind is either a single-chain protein sequence in FASTA format or a monomer protein structure in PDB or mmCIF format and it outputs predicted residue-level binding sites of the input protein with its pre-selected interaction partner. The customizable xBind web interface provides: (i) choice of interaction partners including protein-protein, protein-DNA, and protein-RNA; (ii) on-the-fly AlphaFold-based protein structure prediction for sequence-only inputs; (iii) on-demand selection of the likelihood threshold for calibrating structure-aware binding site annotations; (iv) interactive and interpretable web-based results, including sequence and structural visualizations and plots of residue-level binding likelihoods with user-adjustable threshold calibration; and (v) extensive help information for usage and results interpretation through a web-based tutorial and guide. xBind is freely available at https://fusion.cs.vt.edu/xBind.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.